Article
Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics.
Biochimica et biophysica acta. Reviews on cancer - 1 Apr 2026
Kakde Ganesh S, Dakal Tikam Chand, Maurya Pawan Kumar
Abstract excerpt
Glioblastoma (GBM) is the most malignant form of primary brain tumor in adults, described by profound molecular heterogeneity, rapid progression, and limited therapeutic response. Despite advances in chemotherapy (TMZ), radiotherapy, and surgery, patient outcomes remain poor, with a median survival of 12-15 months. Traditional single-omics studies have identified critical biomarkers such as IDH mutations, MGMT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
